BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2305780)

  • 1. Uptake of muramyl dipeptide by alveolar macrophages in experimental hypersensitivity pneumonitis.
    Richerson HB; Adams P; Iwai Y; Barfknecht CF
    Am J Ind Med; 1990; 17(1):120. PubMed ID: 2305780
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic hypersensitivity pneumonitis produced in the rabbit by the adjuvant effect of inhaled muramyl dipeptide (MDP).
    Richerson HB; Suelzer MT; Swanson PA; Butler JE; Kopp WC; Rose EF
    Am J Pathol; 1982 Mar; 106(3):409-20. PubMed ID: 6101249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of muramyl dipeptide fluorescent congeners by normal rabbit bronchoalveolar lavage cells: a study using flow cytometry.
    Richerson HB; Adams PA; Iwai Y; Barfknecht CF
    Am J Respir Cell Mol Biol; 1990 Feb; 2(2):171-81. PubMed ID: 2306373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal metabolism of muramyl dipeptide.
    Zikos D; Krueger J; Peterson DR
    Contrib Nephrol; 1988; 68():19-25. PubMed ID: 3233994
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulation of mouse resistance to bacterial infection with muramyl dipeptide glycoside.
    Kalyuzhin OV; Kalina NG; Bashtanenko AF; Shkalev MV; Kuzovlev FN; Kalyuzhin VV
    Bull Exp Biol Med; 2003 May; 135(5):452-5. PubMed ID: 12910284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
    Phillips NC; Rioux J; Tsao MS
    Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific binding sites of muroctasin on murine macrophages.
    Akasaki M; Masayasu H; Tsukada W; Takegoshi T
    Arzneimittelforschung; 1988 Jul; 38(7A):978-80. PubMed ID: 3190804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
    Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-produced muramyl peptide contaminants as adjuvants in cell-transfer experiments.
    Westall FC; Root-Bernstein RS
    Mol Immunol; 1985 Apr; 22(4):505-6. PubMed ID: 4033669
    [No Abstract]   [Full Text] [Related]  

  • 11. Syntheses of polymeric vesicles containing partial structures of N-acetyl-muramyl-dipeptide (MDP).
    Hönig H; Zenk R
    Chem Phys Lipids; 1990 Mar; 53(4):347-56. PubMed ID: 2340605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
    Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
    J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of muramyl dipeptide on the secretory immune response.
    Butler JE; Richerson HB; Swanson PA; Kopp WC; Suelzer MT
    Ann N Y Acad Sci; 1983 Jun; 409():669-87. PubMed ID: 6575718
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
    Nagao S; Sato K; Osada Y
    Arzneimittelforschung; 1988 Jul; 38(7A):999-1002. PubMed ID: 3142490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of the proliferative response of thymocytes to phytohemagglutinin by the muramyl dipeptide1.
    Iribe H; Koga T
    Cell Immunol; 1984 Oct; 88(1):9-15. PubMed ID: 6332683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptide.
    Masek K; Zaoral M; Jezek J; Straka R
    Experientia; 1978 Oct; 34(10):1363-4. PubMed ID: 738426
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of muramyl dipeptide on superoxide anion release and on anti-microbial activity of human macrophages.
    Wilson CB; Bohnsack J; Weaver WM
    Clin Exp Immunol; 1982 Aug; 49(2):371-6. PubMed ID: 6290115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulation of macrophages by muramyl peptides: recent findings concerning somnogenic activity of muramyl peptides and monokine.
    Leclerc C; Chedid L
    Int J Tissue React; 1984; 6(3):215-8. PubMed ID: 6332794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages produce somnogenic and pyrogenic muramyl peptides during digestion of staphylococci.
    Johannsen L; Wecke J; Obál F; Krueger JM
    Am J Physiol; 1991 Jan; 260(1 Pt 2):R126-33. PubMed ID: 1992813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific binding sites for muramyl peptides on murine macrophages.
    Silverman DH; Krueger JM; Karnovsky ML
    J Immunol; 1986 Mar; 136(6):2195-201. PubMed ID: 3950411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.